Development and initial psychometric evaluation of a COVID-related psychosocial experiences questionnaire for cancer survivors

Sáez-Clarke, Estefany; Otto, Amy K.; Prinsloo, Sarah; Natori, Akina; Wagner, Richard W.; Gomez, Telma; Ochoa, Jewel; Tworoger, Shelley S.; Ulrich, Cornelia M.; Hathaway, Cassandra A.; Peoples, Anita R.; Antoni, Mike; Bower, Julienne E.; Cohen, Lorenzo; Penedo, Frank J.

doi:10.1007/s11136-023-03456-4

Cited by 6 publications

(2 citation statements)

References 82 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This measure was developed by experts in clinical psychology, social work, and oncology from UM, MDACC, and the University of California Los Angeles, drawing from published measures assessing the impact of pandemics (e.g., H1N1) and major stressors like 9/11, instruments commonly used in cancer populations [27][28][29], and feedback from cancer patients, survivors, and family members. See Sa ´ez-Clarke et al (in press) for additional details of the development and psychometric evaluation of the COVID-PPE [30].…”

Section: Methodsmentioning

confidence: 99%

Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States

Otto,

Prinsloo,

Natori

et al. 2024

PLoS ONE

Self Cite

View full text Add to dashboard Cite

Objective Little evidence exists on the impact of the COVID-19 pandemic on cancer survivors, limiting recommendations to improve health-related quality of life (HRQoL) in this population. We describe survivors’ pandemic experiences and examine associations between COVID-19-related exposures, psychosocial experiences, and HRQoL. Methods Between May 2020-April 2021, survivors completed cross-sectional questionnaires capturing COVID-19-related exposures (e.g., exposure to virus, job loss); psychosocial experiences (i.e., COVID-19-related anxiety/depression, disruptions to health care and daily activities/social interactions, satisfaction with providers’ response to COVID, financial hardship, perceived benefits of the pandemic, social support, and perceived stress management ability); and HRQoL. Results Data were collected from N = 11,325 survivors in the United States. Participants were mostly female (58%), White (89%) and non-Hispanic (88%), and age 63 on average. Breast cancer was the most common diagnosis (23%). Eight percent of participants reported being exposed to COVID-19; 1% tested positive. About 6% of participants lost their jobs, while 24% lost household income. Nearly 30% avoided attending in-person oncology appointments because of the pandemic. Poorer HRQoL was associated with demographic (younger age; female; non-Hispanic White), clinical (Medicare; stage IV disease; hematologic/digestive/respiratory system cancer), and psychosocial factors (low perceived benefits and stress management ability; more disruption to health care and daily activities/social interactions; financial hardship). Conclusions COVID-19-related stressors were associated with various psychosocial experiences in cancer survivors, and these psychosocial experiences were associated with HRQoL above and beyond demographic and clinical factors.

show abstract

Section: Methodsmentioning

confidence: 99%

Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States

Otto,

Prinsloo,

Natori

et al. 2024

PLoS ONE

Self Cite

View full text Add to dashboard Cite

show abstract

“…Catchment area residents who reported that they decided not to attend an appointment not already canceled/postponed due to COVID-19 or they or their doctor/clinic postponed any cancer screening (Pap test, stool blood test, colonoscopy, mammogram, or PSA test) appointment were categorized as experiencing care disruption. Questions were drawn from validated measures assessing the impact of major life disruptions such as natural disasters, and pandemics such as H1N1 ( Saez-Clarke et al, 2023 ).…”

Section: Methodsmentioning

confidence: 99%

Understanding disruptions in cancer care to reduce increased cancer burden

Davis

Ackermann

Klesges

et al. 2023

eLife

View full text Add to dashboard Cite

Background: This study seeks to understand how and for whom COVID-19 disrupted cancer care to understand the potential for cancer health disparities across the cancer prevention and control continuum.Methods: In this cross-sectional study, participants age 30+ residing in an 82-county region in Missouri and Illinois completed an online survey from June-August 2020. Descriptive statistics were calculated for all variables separately and by care disruption status. Logistic regression modeling was conducted to determine the correlates of care disruption.Results: Participants (N=680) reported 21% to 57% of cancer screening or treatment appointments were canceled/postponed from March 2020 through the end of 2020. Approximately 34% of residents stated they would need to know if their doctor's office is taking the appropriate COVID-related safety precautions to return to care. Higher education (OR=1.26, 95%CI:1.11- 1.43), identifying as female (OR=1.60, 95%CI:1.12-2.30), experiencing more discrimination in healthcare settings (OR=1.40, 95%CI:1.13-1.72), and having scheduled a telehealth appointment (OR=1.51, 95%CI:1.07-2.15) were associated with higher odds of care disruption. Factors associated with care disruption were not consistent across races. Higher odds of care disruption for White residents were associated with higher education, female identity, older age, and having scheduled a telehealth appointment, while higher odds of care disruption for Black residents were associated only with higher education.Conclusions: This study provides an understanding of the factors associated with cancer care disruption and what patients need to return to care. Results may inform outreach and engagement strategies to reduce delayed cancer screenings and encourage returning to cancer care.Funding Support: This study was supported by the National Cancer Institute's Administrative Supplements for P30 Cancer Center Support Grants (P30CA091842-18S2 and P30CA091842-19S4). Kia L. Davis, Lisa Klesges, Sarah Humble, and Bettina Drake were supported by the National Cancer Institute's P50CA244431 and Kia L. Davis was also supported by the Breast Cancer Research Foundation. Callie Walsh-Bailey was supported by NIMHD T37 MD014218. The content does not necessarily represent the official view of these funding agencies and is solely the responsibility of the authors.

show abstract

Well-being and stress vulnerability in ovarian cancer survivors during the COVID-19 pandemic

Telles,

Zia,

Greteman

et al. 2023

Journal of Psychosocial Oncology

View full text Add to dashboard Cite

Development and initial psychometric evaluation of a COVID-related psychosocial experiences questionnaire for cancer survivors

Cited by 6 publications

References 82 publications

Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States

Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States

Understanding disruptions in cancer care to reduce increased cancer burden

Well-being and stress vulnerability in ovarian cancer survivors during the COVID-19 pandemic

Contact Info

Product

Resources

About